0001346302-21-000060.txt : 20210608
0001346302-21-000060.hdr.sgml : 20210608
20210608190930
ACCESSION NUMBER: 0001346302-21-000060
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210608
FILED AS OF DATE: 20210608
DATE AS OF CHANGE: 20210608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HALKUFF DAWN
CENTRAL INDEX KEY: 0001743658
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38536
FILM NUMBER: 211003507
MAIL ADDRESS:
STREET 1: C/O XERIS PHARMACEUTICALS
STREET 2: 180 N. LASALLE ST., STE. 1800
CITY: CHICAGO
STATE: IL
ZIP: 60601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001346302
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203352427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 180 NORTH LASALLE STREET
STREET 2: SUITE 1600
CITY: CHICAGO
STATE: IL
ZIP: 60601
BUSINESS PHONE: 844-445-5704
MAIL ADDRESS:
STREET 1: 180 NORTH LASALLE STREET
STREET 2: SUITE 1600
CITY: CHICAGO
STATE: IL
ZIP: 60601
4
1
wf-form4_162319374400964.xml
FORM 4
X0306
4
2021-06-08
0
0001346302
XERIS PHARMACEUTICALS INC
XERS
0001743658
HALKUFF DAWN
C/O XERIS PHARMACEUTICALS, INC.
180 N. LASALLE STREET, SUITE 1600
CHICAGO
IL
60601
1
0
0
0
Stock Option (Right to Buy)
3.9
2021-06-08
4
A
0
11228
0
A
2031-06-08
Common Stock
11228.0
11228
D
Such options will vest in full upon the earlier to occur of June 8, 2022 or the date of the Company's next annual meeting of stockholders.
/s/ Beth Hecht, as Attorney-in-Fact
2021-06-08